Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells

Melanoma Research

Volumn 2, Issue 5, 1992, Pages 305-314

  Benathan, M ^a   Alvero Jackson, H ^a   Mooy, A M ^a   Scaletta, C ^a   Frenk, E ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Buthionine; Glutathione; Melanin; Melanogenesis; Melanoma cells; Melanosomes; Melphalan

Indexed keywords

BUCLADESINE; BUTHIONINE SULFOXIMINE; CATECHOL OXIDASE; DOPA; GLUTATHIONE; GLUTATHIONE TRANSFERASE; MELANIN; MELPHALAN;

ARTICLE; CELL DIFFERENTIATION; CELL GRANULE; CELL LEVEL; CELL LINE; CELL SHAPE; CONTROLLED STUDY; DENDRITE; DRUG CYTOTOXICITY; DRUG SENSITIVITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MELANOGENESIS; MELANOMA CELL; MELANOSOME;

BUCLADESINE; BUTHIONINE SULFOXIMINE; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EYE NEOPLASMS; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HUMAN; KINETICS; MELANINS; MELANOMA; MELPHALAN; METHIONINE SULFOXIMINE; MICROSCOPY, ELECTRON; MONOPHENOL MONOOXYGENASE; NEOPLASM STAGING; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0027477750     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/00008390-199212000-00003     Document Type: Article

References (68)

1. Clark WH Jr, Heggeler BT, Bretton R. Electron microsope observations of human cutaneous melanomas correlated with their biologic behaviour. In: Melanoma and Skin Cancer. Proceedings of the International Cancer Conference, Sydney. Sydney: VCN Blight, Government Printer, 1972: 121-141.
2. Foa C, Aubert C. Ultrastructural comparison between culture and tumor cells of human malignant melanoma. Cancer Res 1977; 37: 3957-3963.
3. Prota G, Rosman H, Rosengren AM, Rosengren E. Phaeomelanic pigments from a human melanoma. Experientia 1976; 32: 970-971.
4. Ito S, Jimbow K. Quantitative analysis of eumelanin and pheomelanin in hair and melanomas. J Invest Dermatol 1983; 80: 268-272.
5. Siegrist W, Solca F, Stutz S, et al. Characterization of receptors for a-melanocyte-stimulating hormone on human melanoma cells. Cancer Res 1989; 49: 6352-6358.
6. Tatro JB, Atkins M, Mier JW, et al. Melanotropin receptors demonstrated in situ in human melanoma. J Clin Invest 1990; 85: 1825-1832.
7. Schallreuter KU, Wood JM. New aspects in the pathophysiology of cutaneous melanoma: a review of the role of thioproteins and the effect of nitrosoureas. Melanoma Res 1991; 1: 159-167.
8. Houghton AN, Real FX, Davis LJ, et al. Phenotypic heterogeneity of melanoma: relation to the differentiation program of melanoma cells. J Exp Med 1987; 164: 812-829.
9. Ings RMJ. The melanin binding of drugs and its implications. Drug Metab Rev 1984; 15: 1183-1212.
10. Larsson BS. Melanin-affinic thioureas as selective melanoma seekers. Melanoma Res 1991; 1: 85-90.
11. Mason HS, Ingram DJE, Allen B. The free radical property of melanins. Arch Biochem Biopbys 1960: 83: 225-230.
12. Debing I, Ijzerman AP, Vauquelin G. Melanosome binding and oxidation-reduction properties of synthetic L-DOPA-melanin as in vitro tests for drug toxicity. Mol Pharmacol 1988; 33: 470-476.
13. Benathan M, Wyler H. Quantitative approaches to melanin structure. Yale J Biol Med 1980; 53: 389-390.
14. Pawelek J, Körner A, Bergstrom A, Bologna J. New regulators of melanin biosynthesis and the autodestruction of melanoma cells. Nature 1980; 286: 617-619.
15. Fujita K, Ito S, Inoue S, et al. Selective toxicity of 5-S-cysteinyldopa, a melanin precursor, to tumor cells in vitro and in vivo. Cancer Res 1980; 40: 2543-2546.
16. Wick MM. Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells. J Invest Dermatol 1989; 92: 329S-331S.
17. Riley PA. Melanogenesis: a realistic target for antimelanoma therapy? Eur J Cancer 1991; 27: 1172-1177.
18. Frenk E, Ott F. Evaluation of the toxicity of the monoethyl ether of hydroquinone for mammalian melanocytes and melanoma cells. J Invest Dermatol 1971; 56: 287-293.
19. Riley PA. Mechanism of pigment-cell toxicity produced by hydroxyanisole. J Pathol 1970; 101: 163-169.
20. Wick MM, Byers L, Frei E. L-dopa: selective toxicity for melanoma cells in vitro. Science 1977; 197: 468-69.
21. Penney KB, Smith CJ, Allen JC. Depigmenting action of hydroquinone depends on disruption of fundamental cell processes. J Invest Dermatol 1984; 82: 308-310.
22. Borovansky J, Mirejovsky P, Riley PA. Possible relationship between abnormal melanosome structure and cytotoxic phenomena in malignant melanoma. Neoplasma 1991;38: 393-400.
23. Meister A. Glutathione metabolism and its selective modification. J Biol Chem 1988; 263: 17205-17208.
24. Lewis AD, Hickson ID, Robson CN, et al. Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards. Proc Natl Acad Sci USA 1988; 85: 8511-8515.
25. Ozols RF, O’Dwyer PJ, Hamilton TC, Young RC. The role of glutathione in drug resistance. Cancer Treat Rev 1990; 17 (suppl. A): 45-50.
26. 1 confers resistance to alkylating agents. Proc Natl Acad Sci USA 1990; 87: 2443-2447.
27. Hansson J, Edgren M, Ehrsson H, Ringborg U, Nilsson B. Effect of D, L-buthionine-S, R-sulfoxime on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Cancer Res 1988; 48: 19-26.
28. Jevtoric-Todorovic V, Guenthner TM. Sensitization of human melanoma cells to melphalan cytotoxicity by Adriamycin and Carmustine. J Cancer Res Clin Oncol 1991; 117: 313-320.
29. Hansson J, Berhane K, Castro VM, Jungnelius U, Mannervik B, Ringborg U. Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid. Cancer Res 1991; 51: 94-98.
30. Mannervik B, Castro VM, Danielson UH, Tahir MK, Hansson J, Ringborg U. Expression of class Pi glutathione transferase in human malignant melanoma cells. Carcinogenesis 1987; 8: 1929-1932.
31. Shea TC, Kelley SL, Henner WD. Identification of an anionic form of glutathione transferase present in many human tumors and human tumor cell lines. Cancer Res 1988; 48: 527-533.
32. Hanada K, Ishikawa H, Tamai K, Hashimoto I, Sato K. Expression of glutathione S-transferase-π in malignant skin tumors. J Dermatol Sci 1991; 2: 18-23.
33. Parsons PG, Lean J, Kable EPW, et al. Relationships between resistance to cross-linking agents and glutathione metabolism, aldehyde dehydrogenase isozymes and adenovirus replication in human tumour cell lines. Biochem Pharmacol 1990; 40: 2641-2649.
34. Wang Y, Teicher BA, Shea TC, et al. Cross-resistance and glutathione-S-transferase-π levels among four human melanoma cell lines selected for alkylating agent resistance. Cancer Res 1989; 49: 6185-6192.
35. Thrall BD, Raha GA, Springer DL, Meadows GG. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs. Pigment Cell Res 1991; 4: 234-239.
36. Guenthner TM, Whalen R, Jevtovic-Todorovic V. Direct measurement of melphalan conjugation with glutathione: studies with human melanoma cells and mammalian liver. J Pharmacol Exp Ther 1992; 260: 1331-1336.
37. Schallreuter KU, Wood JM. Sensitivity and resistance in human metastatic melanoma to the new chloroethylnitrosourea anti-tumor drug Fotemustine. Biochim Biophys Acta 1991; 1096: 277-283.
38. Halprin KM, Ohkawara A. Glutathione and human pigmentation. Arch Dermatol 1966; 94: 355-357.
39. Seiji M, Yoshida T, Itakura H, Irimajiri T. Inhibition of melanin formation by sulfhydryl compounds. J Invest Dermatol 1969; 52: 280-286.
40. Agrup G, Falck B, Rorsman H, Rosengren AM, Rosengren E. Glutathionedopa in malignant melanoma. Acta Dermatovenereol 1977; 57: 221-222.
41. Benedetto JP, Ortonne JP, Voulot C, Khatchadourian C, Prota G, Thivolet J. Role of thiol compounds in mammalian melanin pigmentation. II. Glutathione and related enzymatic activities. J Invest Dermatol 1982; 79: 422-424.
42. Mojamdar M, Ichihashi M, Mishima Y. γ-glutamyl transpeptidase, tyrosinase and 5-S-cysteinyldopa production in melanoma cells. J Invest Dermatol 1983; 81: 119-121.
43. Jara JR, Aroca P, Solano F, Martinez JH, Lozano JA. The role of sulfhydryl compounds in mammalian melanogenesis: the effect of cysteine and glutathione upon tyrosinase and the intermediates of the pathway. Biochim Biophys Acta 1988; 967: 296-303.
44. Wood JM, Schallreuter KU. Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols. Biochim Biophys Acta 1991; 1074: 378-385.
45. Imokawa G. Analysis of initial melanogenesis including tyrosinase transfer and melanosome differentiation through interrupted melanization by glutathione. J Invest Dermatol 1989; 93: 100-107.
46. Prota G, D’Ischia M, Napolitano A. The regulatory role of sulfhydryl compounds in melanogenesis. Pigment Cell Res 1988; 1: 48-53.
47. Rorsman H, Albertsson E, Edholm LE, Hansson C, Ögren L, Rosengren E. Thiols in the melanocyte. Pigment Cell Res 1988; 1: 54-60.
48. Karg E, Odh G, Rosengren E, Wittbjer A, Rorsman H. Melanin-related biochemistry of IGR 1 human melanoma cells. Melanoma Res 1991; 1: 5-13.
49. Dizdar N, Kagedal B, Smeds S, Arstrand K. A high-sensitivity fluorometric high-performance liquid chromatography method for determination of glutathione and other thiols in cultured melanoma cells, microdialysis samples from melanoma tissue, and blood plasma. Melanoma Res 1991; 1: 33-42.
50. Coates A, Tripp E. Glutathione content of human malignant melanoma cell lines: correlation of flow cytometric and biochemical assays, and application to human tumour aspirates. Melanoma Res 1991; 1: 327-332.
51. Lowry OH, Rosebrough NJ, Farr AL, Randall RS. Protein measurements with the Folin phenol reagent. J Biol CHem 1951; 193: 265-275.
52. Wrathall JR, Oliver C, Silagi S, Essner E. Suppression of pigmentation in mouse melanoma cells by 5-bromodeoxyuridine. J Cell Biol 1973; 57: 406-423.
53. Gordon PR, Mansur CP, Gilchrest BA. Regulation of human melanocyte growth, dendricity and melanization by keratinocyte derived factors. J Invest Dermatol 1989; 92: 565-572.
54. Habig WH, Pabst MJ, Jakoby WB. Glutathione transferases, the first enzymatic step in mercapturic acid formation. J Biol Chem 1974; 249: 7130-7139.
55. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 1969; 27: 502-522.
56. Griffith OW. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal Biochem 1990; 106: 207-212.
57. Hunter JAA, Zaynoun S, Paterson WD, Bleehen SS, Mackie R, Cochran AJ. Cellular fine structure in the invasive nodules of different histogenetic types of malignant melanoma. Br J Dermatol 1978; 98: 255-272.
58. Giuffrè L, Schreyer M, Mach JP, Carrel Stefan. Cyclic AMP induces differentiation in vitro of human melanoma cells. Cancer 1988; 61: 1132-1141.
59. Joshi PC, Carraro C, Pathak MA. Involvement of reactive oxygen species in the oxidation of tyrosine and dopa to melanin and in skin tanning. Biochem Biophys Res Commun 1987; 142: 265-274.
60. 2 system.
61. Chakraborty AK, Ichihashi M, Mishima Y. Effect of DOPA-loading on glutathione metabolising enzymes and tyrosinase in relation to 5-S-cysteinyl-DOPA genesis in cultured B-16 melanoma cells. J Dermatol Sci 1991; 2: 329-335.
62. Kable EPW, Favier D, Parsons PG. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S, R)-sulfoximine. Cancer Res 1989; 49: 2327-2331.
63. Prezioso JA, Fitzgerald GB, Wick MM. Effects of tyrosinase activity on the toxicity of 3, 4-dihydroxybenzylamine and buthionine sulfoximine in human melanoma cells. Pigment Cell Res 1990; 3: 49-54.
64. Thrall BD, Meadows GG. Effect of L-dopa methylester and glutathione depletion on murine B16BL6 melanoma growth in vitro. J Invest Dermatol 1991; 97: 1073-1077.
65. Dulik DM, Hilton J, Fenselau C. Characterization of melphalan-glutathione adducts whose formation is catalyzed by gluathione-S-transferase. Biochem Pharmacol 1986; 35: 3405-3409.
66. Mishima Y, Hatta S, Ohyama Y, Inazu M. Induction of melanogenesis suppression: cellular pharmacology and mode of differential action. Pigment Cell Res 1988; 1: 367-374.
67. Kameyama K, Jiménez M, Muller J, Ishida Y, Hearing VJ. Regulation of mammalian melanogenesis by tyrosinase inhibition. Differentiation 1989; 42: 28-36.
68. Ando S, Suemoto Y, Yamamoto S, Ohyama Y, Mishima Y. Separation of melanogenic inhibitors in pigment cells and melanogenesis control activities. Fragrance J 1990; 18: 78-85.